Strategies to Optimize Your Drug-Drug Interaction Program, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will provide an overview of in vitro drug-drug interaction (DDI) assays, as well as the use of PBPK modeling to help interpret results and understand how they can be used to obtain a DDI waiver. The presenters will also highlight key study design considerations related to clinical DDI evaluation, how to optimize complex clinical DDI assessments, as well as understand PopPK strategies to further evaluate DDI risk and support labeling.

Join this educational webinar to hear three specialists share their expertise on how sponsors can optimize their DDI evaluation process, spanning from preclinical to clinical.

What sponsors always wanted to know about DDI waivers, cocktails and modeling, but were afraid to ask.

As today’s patients are prescribed an increasing number of medications, drug development sponsors must be aware of potential drug-drug interactions (DDIs) for their product in order to avoid unexpected pharmacological effects and to provide accurate labeling.

Join this educational webinar to hear three specialists share their expertise on how sponsors can optimize their DDI evaluation process, spanning from preclinical to clinical.

The first part of this webinar will provide an overview of in vitro DDI assays and the use of physiologically-based pharmacokinetic (PBPK) modeling to help interpret results, support waivers and focus on interactions with clinical DDI risk, before moving into study design considerations to ensure robust and efficient assessment. Population pharmacokinetics (PopPK) strategies will then be presented to explain how modeling and simulation can help evaluate DDI risk and support labeling.

Join experts from Covance, Dan Albaugh, MS, Associate Director, Global Metabolism and Environmental Sciences; Andreas M. Reichl, MD, Scientific Director, Clinical Pharmacology, Medical and Scientific Affairs; and Brandon Gufford, PharmD, PhD, Senior Pharmacokineticist, Clinical Pharmacology Services, in a live webinar on Monday, December 7, 2020 at 10am EST (3pm GMT/UK).

For more information, or to register for this event, visit Strategies to Optimize Your Drug-Drug Interaction Program.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ayesha Rashid
Xtalks
+1 (416) 977-6555 x 272
Email >
Visit website